TME Pharma NV Sustainability Reports
TME Pharma N.V. is a clinical-stage biopharmaceutical company focused on developing novel therapies for aggressive cancers by targeting the tumor microenvironment. Its lead product candidates specialize in approaches that enhance the effectiveness of standard cancer treatments.
Sector: Manufacturing
Country: Germany
Exchange: Euronext Paris
LEI: 724500EPNADXWZ58U595
FIGI: BBG00B8NQ1C2
1 reports from 2024 to 2024